The biopharmaceutical industry is on the brink of unprecedented breakthroughs, with the potential to revolutionize health care, reduce the burden of disease and create a healthier future for all.
Over the past 25 years, medical breakthroughs have transformed health care and offered hope to millions.
We’ve effectively cured hepatitis C, turned HIV/AIDS into a manageable condition, cured many cases of childhood leukemia, revolutionized cancer treatment and developed therapies to combat obesity and related conditions. These achievements demonstrate the life-changing power of innovative medicines.
But our work isn’t done.
Diseases like Alzheimer’s, cancer, heart disease and rare genetic conditions still challenge patients and strain our health care system.
Our industry is committed to making big, bold investments in medicines that will change the course of disease for all of us — because all of us are patients at some point.
Every day, thousands of scientists across America are tackling the toughest diseases to build a healthier future.
Vaccines have played a critical role in helping prevent some of the most dangerous illnesses, greatly reducing the severity and toll of many diseases.
Our Work in Action
With the support of a unique ecosystem and policy environment that foster transformative advancements, this progress positions America as the global leader in biopharmaceutical innovation.
